Skip to main content
. 2017 Sep 1;104(8):665–672. doi: 10.1136/heartjnl-2017-311983

Table 2.

Summary statistics of the suggested National Institute for Health and Care Excellence algorithm according to high-sensitivity troponin assay and Thrombolysis In Myocardial Infarction (TIMI) score threshold

Hs-cTnT Hs-cTnI
TIMI score 0 2×2 MACE No MACE MACE No MACE
 Test positive: hs-cTn>LoD or TIMI>0 374 2219 440 3140
 Test negative (rule-out): hs-cTn≤LoD and TIMI=0 2 564 5 947
Sensitivity (95% CI) 99.5% (98.1% to 99.9%) 98.9% (97.4% to 99.6%)
Meta-estimate of sensitivity (95% CI) 98.7% (96.5% to 99.6) 98.5% (95.4% to 99.5%)
Negative predictive value (95% CI) 99.6% (98.7% to 100%) 99.5% (98.8% to 99.8%)
Specificity (95% CI) 20.3% (18.8% to 21.8%) 23.2% (21.9% to 24.5%)
Positive predictive value (95% CI) 14.4% (13.1% to 15.8%) 12.3% (11.2% to 13.4%)
Proportion of patients potentially suitable for early discharge (95% CI) 17.9% (16.6% to 19.3%) 21.0% (19.9% to 22.2%)
TIMI score≤1 2×2 MACE No MACE MACE No MACE
 Test positive: hs-cTn>LoD or TIMI>1 372 1900 438 2477
 Test negative (rule-out): hs-cTn≤LoD and TIMI≤1 4 883 7 1610
Sensitivity (95% CI) 98.9% (97.3% to 99.7%) 98.4% (96.8% to 99.4%)
Meta-estimate of sensitivity (95% CI) 98.4% (95.7% to 99.4%) 98.2% (94.5% to 99.4%)
Negative predictive value (95% CI) 99.5% (98.8% to 99.9%) 99.6% (99.1% to 99.8%)
Specificity (95% CI) 31.7% (30.0% to 33.5%) 39.4% (37.9% to 40.9%)
Positive predictive value (95% CI) 16.4% (14.9% to 18.0%) 15.0% (13.7% to 16.4%)
Proportion of patients potentially suitable for early discharge (95% CI) 28.1% (26.5% to 29.7%) 35.7% (34.3% to 37.1%)
TIMI score≤2 2×2 MACE No MACE MACE No MACE
 Test positive: hs-cTn>LoD or TIMI>2 369 1736 433 2216
 Test negative (rule-out): hs-cTn≤LoD and TIMI≤2 7 1047 12 1871
Sensitivity (95% CI) 98.1% (96.2% to 99.2%) 97.3% (95.3% to 98.6%)
Meta-estimate of sensitivity (95% CI) 97.4% (94.7% to 98.8%) 97.7% (92.4% to 99.3%)
Negative predictive value (95% CI) 99.3% (98.6% to 99.7%) 99.4% (98.9% to 99.7%)
Specificity (95% CI) 37.6% (35.8% to 39.5%) 45.8% (44.2% to 47.3%)
Positive predictive value (95% CI) 17.5% (15.9% to 19.2%) 16.3% (15.0% to 17.8%)
Proportion of patients potentially suitable for early discharge (95% CI) 33.4% (31.7% to 35.0%) 40.5% (39.0% to 41.9%)

MACE, major adverse cardiac event; Hs-cTn: high-sensitivity cardiac troponin T or I; TIMI, thrombolysis inmyocardial infarction.